Last reviewed · How we verify

NCT06816420

Effect Of Local Cold Applıcatıon On Paın and Vıtal Sıgns Durıng Port Catheter Needle Insertıon

Completed NA Last updated 16 April 2025
What this trial tests

NA trial testing Cold Application in Catheter Placement and Perceived Pain in 64 participants. Completed in 8 April 2025.

Timeline
4 March 2025
Primary endpoint
8 April 2025
8 April 2025

Quick facts

Lead sponsorNecmettin Erbakan University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposeother
Enrollment64
Start date4 March 2025
Primary completion8 April 2025
Estimated completion8 April 2025
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

Necmettin Erbakan University

Who can join

Adults 18 to 65, any sex, with Catheter Placement and Perceived Pain or Vital Sign Monitoring. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

In this study, the effect of cold application on the pain experienced during port catheter needle insertion and the change in the patient's vital signs will be evaluated. It is thought that with this application, patients will experience less pain during port catheter needle insertion. The change in the patient's vital signs and pain status will also be evaluated. The research will be conducted in the outpatient chemotherapy department of a Hospital.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Cold Application

Trials testing the same drug.

Other Necmettin Erbakan University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06816420.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing